Similar articles for PMID: 28663267

Year	Number of Results
1995	3
1998	1
2001	2
2003	3
2004	2
2005	1
2006	4
2007	1
2008	2
2009	5
2010	8
2011	5
2012	12
2013	10
2014	10
2015	10
2016	12
2017	10
2018	12
2019	12
2020	7
2021	10
2022	5
2023	2
2024	0

1

Comparison of Gadoterate Meglumine and Gadobutrol in the MRI Diagnosis of Primary Brain Tumors: A Double-Blind Randomized Controlled Intraindividual Crossover Study (the REMIND Study).

Maravilla KR, San-Juan D, Kim SJ, Elizondo-Riojas G, Fink JR, Escobar W, Bag A, Roberts DR, Hao J, Pitrou C, Tsiouris AJ, Herskovits E, Fiebach JB. Maravilla KR, et al. AJNR Am J Neuroradiol. 2017 Sep;38(9):1681-1688. doi: 10.3174/ajnr.A5316. Epub 2017 Jun 29. AJNR Am J Neuroradiol. 2017. PMID: 28663267 Free PMC article. Clinical Trial.

2

Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting.

Anzalone N, Scarabino T, Venturi C, Cristaudo C, Tartaro A, Scotti G, Zimatore D, Floris R, Carriero A, Longo M, Cirillo M, Cova MA, Gatti S, Voth M, Colosimo C. Anzalone N, et al. Eur J Radiol. 2013 Jan;82(1):139-45. doi: 10.1016/j.ejrad.2011.07.005. Epub 2011 Sep 3. Eur J Radiol. 2013. PMID: 21890295 Clinical Trial.

3

Clinical Efficacy of Reduced-Dose Gadobutrol Versus Standard-Dose Gadoterate for Contrast-Enhanced MRI of the CNS: An International Multicenter Prospective Crossover Trial (LEADER-75).

Liu BP, Rosenberg M, Saverio P, Weon YC, Peters S, Ardellier FD, Boeckenhoff A, Endrikat J. Liu BP, et al. AJR Am J Roentgenol. 2021 Nov;217(5):1195-1205. doi: 10.2214/AJR.21.25924. Epub 2021 Jun 16. AJR Am J Roentgenol. 2021. PMID: 34133205 Clinical Trial.

4

MR Angiography at 3 T of Peripheral Arterial Disease: A Randomized Prospective Comparison of Gadoterate Meglumine and Gadobutrol.

Loewe C, Arnaiz J, Krause D, Marti-Bonmati L, Haneder S, Kramer U; DALIA Study Group. Loewe C, et al. AJR Am J Roentgenol. 2015 Jun;204(6):1311-21. doi: 10.2214/AJR.14.12604. AJR Am J Roentgenol. 2015. PMID: 26001243 Clinical Trial.

5

The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).

Vaneckova M, Herman M, Smith MP, Mechl M, Maravilla KR, Weichet J, Spampinato MV, Žižka J, Wippold FJ 2nd, Baima JJ, Babbel R, Bültmann E, Huang RY, Buhk JH, Bonafé A, Colosimo C, Lui S, Kirchin MA, Shen N, Pirovano G, Spinazzi A. Vaneckova M, et al. AJNR Am J Neuroradiol. 2015 Sep;36(9):1589-98. doi: 10.3174/ajnr.A4468. Epub 2015 Jul 16. AJNR Am J Neuroradiol. 2015. PMID: 26185325 Free PMC article. Clinical Trial.

6

MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.

Saake M, Langner S, Schwenke C, Weibart M, Jansen O, Hosten N, Doerfler A. Saake M, et al. Eur Radiol. 2016 Mar;26(3):820-8. doi: 10.1007/s00330-015-3889-7. Epub 2015 Jun 30. Eur Radiol. 2016. PMID: 26123410 Clinical Trial.

7

Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.

Robert P, Vives V, Grindel AL, Kremer S, Bierry G, Louin G, Ballet S, Corot C. Robert P, et al. Radiology. 2020 Jan;294(1):117-126. doi: 10.1148/radiol.2019182953. Epub 2019 Oct 29. Radiology. 2020. PMID: 31660804

8

Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.

Attenberger UI, Runge VM, Jackson CB, Baumann S, Birkemeier K, Michaely HJ, Schoenberg SO, Reiser MF, Wintersperger BJ. Attenberger UI, et al. Invest Radiol. 2009 May;44(5):251-6. doi: 10.1097/RLI.0b013e31819ba711. Invest Radiol. 2009. PMID: 19550376

9

Dynamic and static magnetic resonance angiography of the supra-aortic vessels at 3.0 T: intraindividual comparison of gadobutrol, gadobenate dimeglumine, and gadoterate meglumine at equimolar dose.

Kramer JH, Arnoldi E, François CJ, Wentland AL, Nikolaou K, Wintersperger BJ, Grist TM. Kramer JH, et al. Invest Radiol. 2013 Mar;48(3):121-8. doi: 10.1097/RLI.0b013e31827752b4. Invest Radiol. 2013. PMID: 23211552 Free PMC article. Clinical Trial.

10

Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.

Lee CH, Vellayappan B, Taupitz M, Hamm B, Asbach P. Lee CH, et al. Eur Radiol. 2019 Dec;29(12):6982-6990. doi: 10.1007/s00330-019-06321-6. Epub 2019 Jul 1. Eur Radiol. 2019. PMID: 31264013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

119 results

Results by year